Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
about
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug responsePharmacogenetic tests for antipsychotic medications: clinical implications and considerations.Does olanzapine warrant clinical pharmacokinetic monitoring in schizophrenia?Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia.Pharmacogenetics of olanzapine metabolism.Clinical applications of CYP genotyping in psychiatry.CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers.Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects.Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation.Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients.Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non-smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3.
P2860
Q28252209-E2384383-5DF6-45B3-A7D5-0F60ECA987D1Q37344782-EA570022-3A65-4AE7-AED0-452D35BD1BA8Q37886136-3CC525AF-D147-435A-A5A9-69635CCA5E57Q38103885-3140B05B-6645-44E4-9D31-C597437F43F5Q38127716-1155C5C3-3B99-4B0A-A57B-7A486CBB7FFDQ38247063-6B5B69B5-8ED0-4CC9-9DFF-C4146007DD1AQ42315488-741EAB0C-6F7D-490B-9692-7C51560B5F62Q44367387-9DEFB0BA-822A-409C-85B6-45873FBB418AQ46254583-F0AA27B1-BA5F-40CF-82F8-DEACE650B197Q47384439-48B0C720-132E-4D40-A645-3323EFB0FCC5Q50736144-4D431352-CD14-471D-A90B-7BB97ABBB06CQ50933183-EA100F8E-FB73-40A4-AE90-CA48FF60F599
P2860
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
@en
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
@nl
type
label
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
@en
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
@nl
prefLabel
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
@en
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
@nl
P356
P1476
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.
@en
P2093
R Dahlqvist
P2888
P304
P356
10.1007/S002280100343
P577
2001-09-01T00:00:00Z